Advanced NanoTherapies announced today that it closed an oversubscribed Series A equity financing round.
Los Gatos, California-based Advanced NanoTherapies, which develops the SirPlux Duo drug-coated balloon (DCB) for treating de novo coronary artery disease (CAD) lesions, has now raised $12.5 million in total since September 2020.
Get the full story at our sister site, Drug Delivery Business News.